KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Gross Profit (2019 - 2025)

Historic Gross Profit for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $112.5 million.

  • GoodRx Holdings' Gross Profit rose 674.87% to $112.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $453.9 million, marking a year-over-year increase of 721.13%. This contributed to the annual value of $425.2 million for FY2024, which is 397.93% up from last year.
  • Per GoodRx Holdings' latest filing, its Gross Profit stood at $112.5 million for Q3 2025, which was up 674.87% from $118.2 million recorded in Q2 2025.
  • GoodRx Holdings' 5-year Gross Profit high stood at $118.4 million for Q1 2025, and its period low was $80.7 million during Q1 2021.
  • Over the past 5 years, GoodRx Holdings' median Gross Profit value was $105.4 million (recorded in 2024), while the average stood at $103.5 million.
  • Per our database at Business Quant, GoodRx Holdings' Gross Profit skyrocketed by 3671.43% in 2022 and then plummeted by 1262.08% in 2023.
  • GoodRx Holdings' Gross Profit (Quarter) stood at $106.8 million in 2021, then dropped by 6.35% to $100.0 million in 2022, then rose by 2.91% to $102.9 million in 2023, then grew by 1.81% to $104.8 million in 2024, then grew by 7.39% to $112.5 million in 2025.
  • Its last three reported values are $112.5 million in Q3 2025, $118.2 million for Q2 2025, and $118.4 million during Q1 2025.